Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)

David J Beard* (Corresponding Author), Marion K Campbell, Jane M. Blazeby, Andrew J. Carr, Charles Weijer, Brian H. Cuthbertson, Rachelle Buchbinder, Thomas Pinkney, Felicity Bishop, Jonathan Pugh, Sian Cousins, Ian Harris, L. Stefan Lohmander, Natalie Blencowe, Katie Gillies, Pascal Probst , Carol Brennan, Andrew Cook, Dair Farrah-Hockley, Julian SavulescuRichard Huxtable, Amar Rangan, Irene Tracey, Peter Brocklehurst, Manuela L. Ferreira, Jon Nicholl, Barnaby C. Reeves, Freddie Hamdy, Samuel C. S. Rowley, Jonathan A. Cook

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Placebo comparisons are increasingly being considered for randomised trials assessing the efficacy of surgical interventions. The aim of this paper is to provide a summary of current knowledge on placebo controls in surgical trials.

A placebo control is a complex type of comparison group and, although powerful, presents many challenges in a surgical setting. This review outlines what a placebo-surgical control entails and our understanding of the placebo phenomenon in the context of surgery. It considers when placebo-surgical controls are acceptable (and when they are desirable) in terms of ethical arguments and regulatory requirements, how a placebo-surgical control should be designed, how to identify and mitigate risk for participants in placebo surgical trials, how such trials should be conducted and interpreted.

Use of placebo control is justified in randomised controlled trials of surgical interventions provided there is a strong scientific and ethical rationale. Surgical placebos may be most appropriate where there is poor evidence on the efficacy of the procedure and a justified concern that results of a trial would be associated with high risk of bias, particularly due to the placebo effect. Feasibility work is recommended to optimise RCT design and conduct. This review forms an outline for best practice and provides guidance, in the form of the ASPIRE (Applying Surgical Placebo in Randomised Evaluations) checklist, for those considering the use of a placebo-control in a surgical randomised controlled trial.
Original languageEnglish
Pages (from-to)828-838
Number of pages11
JournalThe Lancet
Volume395
Issue number10226
DOIs
Publication statusPublished - 7 Mar 2020

    Fingerprint

Keywords

  • Guidelines as Topic
  • Humans
  • Placebos
  • Randomized Controlled Trials as Topic/ethics
  • Research Design
  • Surgical Procedures, Operative

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Beard, D. J., Campbell, M. K., Blazeby, J. M., Carr, A. J., Weijer, C., Cuthbertson, B. H., Buchbinder, R., Pinkney, T., Bishop, F., Pugh, J., Cousins, S., Harris, I., Lohmander, L. S., Blencowe, N., Gillies, K., Probst , P., Brennan, C., Cook, A., Farrah-Hockley, D., ... Cook, J. A. (2020). Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines). The Lancet, 395(10226), 828-838. https://doi.org/10.1016/S0140-6736(19)33137-X